Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 11/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | AXL | P30530 | 1/20 | 0.47 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.47 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.47 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9973694 | 0.87 | CYP2A6 (0.49) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL1107870 | 0.84 | CYP2A6 (0.54) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL678010 | 0.84 | KDM4E (0.51) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL10181969 | 0.82 | CYP2A6 (0.67) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL1107892 | 0.82 | RAB9A (0.59) | KDM4ESMN1; SMN2RAB9ANPC1MEN1 | |
| SCHEMBL3194702 | 0.81 | CYP2A6 (0.74) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL9973686 | 0.80 | HPGDS (0.54) | CYP2A6CYP19A1RAB9ANPC1AXL | |
| SCHEMBL1424931 | 0.79 | KDM4E (0.75) | CYP2A6KDM4ESMN1; SMN2CYP19A1RAB9A | |
| SCHEMBL9973683 | 0.79 | HPGDS (0.52) | CYP2A6KDM4ECYP19A1RAB9ANPC1 | |
| SCHEMBL12278881 | 0.76 | HSD17B10 (0.55) | KDM4ESMN1; SMN2RAB9ANPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLC25A11, ELAVL1, SLC26A3 | CYP2A6 4405/4885KDM4E 1968/4885SMN1; SMN2 1611/4885 |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SLC25A11, ELAVL1, SLC26A3 | CYP2A6 4405/4885KDM4E 1968/4885SMN1; SMN2 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.